Sage Therapeutics Inc (NASDAQ: SAGE) remained unchanged at $4.91, before settling in for the price of $4.91 at the close. Taking a more long-term approach,
Sage Therapeutics Inc (NASDAQ: SAGE) on Friday, plunged -5.03% from the previous trading day, before settling in for the closing price of $5.37. Within the
On Tuesday, Sage Therapeutics Inc (NASDAQ: SAGE) opened lower -9.05% from the last session, before settling in for the closing price of $6.30. Price fluctuations
Sage Therapeutics Inc (NASDAQ: SAGE) established initial surge of 6.22% at $6.32, before settling in for the price of $5.95 at the close. Taking a
On Monday, Sage Therapeutics Inc (NASDAQ: SAGE) was -3.97% drop from the session before settling in for the closing price of $6.05. A 52-week range
Sage Therapeutics Inc (NASDAQ: SAGE) started the day on Thursday, with a price decrease of -5.59% at $6.08, before settling in for the price of
On Monday, Sage Therapeutics Inc (NASDAQ: SAGE) was 6.62% up from the session before settling in for the closing price of $8.01. A 52-week range
Sage Therapeutics Inc (NASDAQ: SAGE) established initial surge of 2.61% at $7.85, before settling in for the price of $7.65 at the close. Taking a
During the past 52 weeks, Sage Therapeutics (SAGE) shares have fallen about 25%. Another reason for the decline in quotations is the drug’s inability to
Newsdaemon.com is a Business and Stock news website that covers extensive information on Stock markets and Equities. One of the key emphases of this portal is to widen readers’ knowledge of public and private capital sharing, both in updates and broad analysis.
Copyright © 2024 News Daemon, All rights reserved.
